These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Severe acneiform eruption induced by cetuximab (Erbitux). Lee JE; Lee SJ; Lee HJ; Lee JH; Lee KH Yonsei Med J; 2008 Oct; 49(5):851-2. PubMed ID: 18972607 [TBL] [Abstract][Full Text] [Related]
6. Grover's disease induced by cetuximab. Tscharner GG; Bühler S; Borner M; Hunziker T Dermatology; 2006; 213(1):37-9. PubMed ID: 16778425 [TBL] [Abstract][Full Text] [Related]
7. Cetuximab-induced acneiform eruption and the response to isotretinoin. Vezzoli P; Marzano AV; Onida F; Alessi E; Galassi B; Tomirotti M; Berti E Acta Derm Venereol; 2008; 88(1):84-6. PubMed ID: 18176767 [No Abstract] [Full Text] [Related]
8. Two cases of acneiform eruption induced by inhibitor of epidermal growth factor receptor. Gencoglan G; Ceylan C Skin Pharmacol Physiol; 2007; 20(5):260-2. PubMed ID: 17641540 [TBL] [Abstract][Full Text] [Related]
9. Topical vitamin K1 may not be effective in preventing acneiform rash during cetuximab treatment in patients with metastatic colorectal cancer. Jo JC; Hong YS; Kim KP; Lee JL; Kim HJ; Lee MW; Lim SB; Yu CS; Kim JC; Kim JH; Kim TW Eur J Dermatol; 2013; 23(1):77-82. PubMed ID: 23238388 [TBL] [Abstract][Full Text] [Related]
11. Complications of therapy and a diagnostic dilemma case. Case 2. Cutaneous toxicity induced by cetuximab. Monti M; Mancini LL; Ferrari B; Rahal D; Santoro A J Clin Oncol; 2003 Dec; 21(24):4651-3. PubMed ID: 14673056 [No Abstract] [Full Text] [Related]
12. Cetuximab-induced cutaneous toxicity. Tomková H; Kohoutek M; Zábojníková M; Pospísková M; Ostrízková L; Gharibyar M J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):692-6. PubMed ID: 19925598 [TBL] [Abstract][Full Text] [Related]
13. Images in clinical medicine. Cetuximab-associated acneiform eruption. Moss JE; Burtness B N Engl J Med; 2005 Nov; 353(19):e17. PubMed ID: 16282170 [No Abstract] [Full Text] [Related]
14. Topical therapy with nadifloxacin cream and prednicarbate cream improves acneiform eruptions caused by the EGFR-inhibitor cetuximab - A report of 29 patients. Katzer K; Tietze J; Klein E; Heinemann V; Ruzicka T; Wollenberg A Eur J Dermatol; 2010; 20(1):82-4. PubMed ID: 19797039 [TBL] [Abstract][Full Text] [Related]
15. [Therapy of severe cetuximab-induced acneiform eruptions with oral retinoid, topical antibiotic and topical corticosteroid]. Wollenberg A; Moosmann N; Kroth J; Heinemann V; Klein E Hautarzt; 2007 Jul; 58(7):615-8. PubMed ID: 17146641 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of treatment with tetracyclines to prevent acneiform eruption secondary to cetuximab therapy. Micantonio T; Fargnoli MC; Ricevuto E; Ficorella C; Marchetti P; Peris K Arch Dermatol; 2005 Sep; 141(9):1173-4. PubMed ID: 16172328 [No Abstract] [Full Text] [Related]
17. Papulo-pustular eruption during cetuximab treatment. Satta R; Cuccuru MA; Pirodda C; Cottoni F G Ital Dermatol Venereol; 2008 Feb; 143(1):87-8. PubMed ID: 18833056 [No Abstract] [Full Text] [Related]
18. Management of cutaneous side-effects of cetuximab therapy in patients with metastatic colorectal cancer. Ocvirk J; Cencelj S J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):453-9. PubMed ID: 19793151 [TBL] [Abstract][Full Text] [Related]
19. Cetuximab monotherapy in advanced cervical cancer: a retrospective study with five patients. Hertlein L; Lenhard M; Kirschenhofer A; Kahlert S; Mayr D; Burges A; Friese K Arch Gynecol Obstet; 2011 Jan; 283(1):109-13. PubMed ID: 20180130 [TBL] [Abstract][Full Text] [Related]
20. A double-blind, placebo-controlled study of the safety and efficacy of vitamin K1 ointment for the treatment of patients with cetuximab-induced acneiform eruption. Hashimoto H; Iwasa S; Yanai T; Honma Y; Kato K; Hamaguchi T; Yamada Y; Shimada Y; Namikawa K; Tsutsumida A; Yamazaki N; Yamamoto H Jpn J Clin Oncol; 2013 Jan; 43(1):92-4. PubMed ID: 23136238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]